- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05993377
Prediction of Duration of Mechanical Ventilation in ARDS (PIONEER)
Predicting Length of Mechanical Ventilation in Moderate-to-severe Acute Respiratory Distress Syndrome Using Machine Learning
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The acute respiratory distress syndrome (ARDS) is an important cause of morbidity, mortality, and costs in intensive care units (ICUs) worldwide. Most ARDS patients require mechanical ventilation (MV). Few studies have investigated the prediction of MV duration of ARDS.
For model description and testing, the investigators will extract data from he first three ICU days after diagnosis of moderate-to-severe ARDS from patients included in the de-identified database, which includes 1,000 mechanically ventilated patients enrolled in several observational cohorts in Spain, coordinated by the principal investigator (JV), and funded by the Instituto de Salud Carlos III (ISCIII). The investigators will follow the TRIPOD guidelines and machine learning techniques will be implemented [Random Forest (RF), eXtreme Gradient Boosting (XGBoost), and Logistic regression analysis) for the development and accuracy of prediction models. Disease progression will be tracked along those 3 ICU days to assess lung severity according to Berlin criteria. For external validation, the investigators will use 303 patients enrolled in a contemporary observational study (NCT03145974). The investigators will evaluate the accuracy of prediction models by calculation several statistics, such as sensitivity, specificity, positive predictive value, negative value for each model. The investigators will select the best early prediction model with data captured on the 1st, 2nd, or 3rd day.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Albacete, Spain
- Complejo Hospitalario de Albacete
-
Albacete, Spain, 02006
- Complejo Hospitalario Universitario de Albacete (ICU)
-
Barcelona, Spain, 08036
- Department of Anesthesia, Hospital Clinic
-
Ciudad Real, Spain, 13005
- Hospital General de Ciudad Real (ICU)
-
Cuenca, Spain
- Hospital Virgen De La Luz
-
La Coruña, Spain, 15006
- Hospital Universitario de A Coruña (ICU)
-
León, Spain
- Complejo Hospitalario Universitario de León
-
Madrid, Spain
- Hospital Fundación Jiménez Díaz
-
Madrid, Spain, 28046
- Hospital Universitario La Paz (ICU)
-
Madrid, Spain, 28034
- Hospital Universitario Ramón y Cajal (Anesthesia)
-
Murcia, Spain, 30120
- Hospital Universitario Virgen de Arrixaca (ICU)
-
Málaga, Spain
- Hospital Universitario Carlos Haya
-
Málaga, Spain, 29010
- Hospital Universitario Regional de Malaga Carlos Haya (ICU)
-
Valladolid, Spain, 47012
- Hospital Universitario Río Hortega (ICU)
-
Zamora, Spain, 49022
- Hospital Virgen de la Concha (ICU)
-
-
Las Palmas
-
Las Palmas De Gran Canaria, Las Palmas, Spain, 35019
- Hospital Universitario Dr. Negrin
-
-
Madrid
-
Majadahonda, Madrid, Spain, 28222
- Hospital Universitario Puerta de Hierro (ICU)
-
-
Tenerife
-
Santa Cruz de Tenerife, Tenerife, Spain
- Hospital Universitario NS de Candelaria
-
-
Toledo
-
Talavera de la Reina, Toledo, Spain
- Hospital NS del Prado
-
-
-
-
-
Cardiff, United Kingdom
- Cardiff University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Berlin criteria for moderate to severe acute respiratory distress syndrome
Exclusion Criteria:
- Postoperative patients ventilated <24h
- brain death patients
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Confirmatory cohort
It will contain 303 patients (for external validation)
|
we will use robust machine learning approaches, such as Random Forest and XGBoost.
|
Derivation and testing cohort
It will contain 1000 ARDS patients
|
we will use robust machine learning approaches, such as Random Forest and XGBoost.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Days on mechanical ventilation
Time Frame: from diagnosis to extubation
|
Duration of mechanical ventilation
|
from diagnosis to extubation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ICU mortality
Time Frame: up to 24 weeks
|
mortality in the intensive care unit
|
up to 24 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jesús Villar, Hospital Universitario D. Negrin
Publications and helpful links
General Publications
- Villar J, Ambros A, Mosteiro F, Martinez D, Fernandez L, Ferrando C, Carriedo D, Soler JA, Parrilla D, Hernandez M, Andaluz-Ojeda D, Anon JM, Vidal A, Gonzalez-Higueras E, Martin-Rodriguez C, Diaz-Lamas AM, Blanco J, Belda J, Diaz-Dominguez FJ, Rico-Feijoo J, Martin-Delgado C, Romera MA, Gonzalez-Martin JM, Fernandez RL, Kacmarek RM; Spanish Initiative for Epidemiology, Stratification and Therapies of ARDS (SIESTA) Network. A Prognostic Enrichment Strategy for Selection of Patients With Acute Respiratory Distress Syndrome in Clinical Trials. Crit Care Med. 2019 Mar;47(3):377-385. doi: 10.1097/CCM.0000000000003624.
- Figueroa-Casas JB, Dwivedi AK, Connery SM, Quansah R, Ellerbrook L, Galvis J. Predictive models of prolonged mechanical ventilation yield moderate accuracy. J Crit Care. 2015 Jun;30(3):502-5. doi: 10.1016/j.jcrc.2015.01.020. Epub 2015 Jan 30.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PIFIISC21-36
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Respiratory Distress Syndrome
-
Tanta UniversityRecruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Respiratory Distress Syndrome, PediatricEgypt
-
University Hospital, Clermont-FerrandWithdrawn
-
China-Japan Friendship HospitalNot yet recruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
-
Dr. Behcet Uz Children's HospitalRecruitingAcute Respiratory Distress Syndrome | Acute Respiratory Failure | Pediatric Acute Respiratory Distress Syndrome (PARDS)Turkey
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Acute Respiratory Syndrome Coronavirus 2 | Severe Acute Respiratory Distress SyndromeFrance
-
Intermountain Health Care, Inc.UnknownRespiratory Failure | Acute Respiratory Distress Syndrome (ARDS) | Acute Lung Injury (ALI)United States
-
Aqualung Therapeutics Corp.Not yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Unity Health TorontoRecruitingAcute Respiratory Distress Syndrome (ARDS)Canada, Spain, Italy, Brazil
-
Western University, CanadaEnrolling by invitationCOVID-19 Acute Respiratory Distress SyndromeCanada
-
Ain Shams UniversityCompletedCOVID-19 Acute Respiratory Distress SyndromeEgypt
Clinical Trials on Logistic regression Cross validation Area under the RIC curves Machine learning analysis. .
-
Dr. Negrin University HospitalActive, not recruitingAcute Hypoxemic Respiratory FailureSpain
-
Dr. Negrin University HospitalUnity Health TorontoCompleted